Page last updated: 2024-08-01 20:41:20

leucokinin i

Description

leucokinin I: an eight amino acid neuropeptide found in the nervous system of the bowfly; aa sequence given in first source [MeSH]

Leucokinin I : no description available [CHeBI]

Cross-References

ID SourceID
PubMed CID5491285
CHEBI ID80183
MeSH IDM0223146

Synonyms (13)

Synonym
leucokinin i
104600-89-7
(3s)-3-amino-4-[(2s)-2-[[(2s)-1-[[(2s)-1-[[(2s)-4-amino-1-[[(2s)-1-[[(2s)-1-[(2-amino-2-oxoethyl)amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-y
asp-pro-ala-phe-asn-ser-trp-gly-nh2
leukokinin i
CHEBI:80183
DTXSID90146608
J-001201
glycinamide, l-alpha-aspartyl-l-prolyl-l-alanyl-l-phenylalanyl-l-asparaginyl-l-seryl-l-tryptophyl-
Q27149296
(s)-4-((s)-2-(((5s,8s,11s,14s,17s)-5-((1h-indol-3-yl)methyl)-1-amino-11-(2-amino-2-oxoethyl)-14-benzyl-8-(hydroxymethyl)-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazaoctadecan-17-yl)carbamoyl)pyrrolidin-1-yl)-3-amino-4-oxobutanoic acid
glycinamide,l-alpha-aspartyl-l-prolyl-l-alanyl-l-phenylalanyl-l-asparaginyl-l-seryl-l-tryptophyl-
AKOS040744659

Drug Classes (1)

ClassDescription
peptideAmide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc.

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (76.92)18.2507
2000's3 (23.08)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
enkephalin, leucinepeptide00low000000
2-[[2-formamido-4-(methylthio)-1-oxobutyl]amino]propanoic acidpeptide00low000000
n-formylmethionylphenylalaninepeptide00low000000
substance ppeptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
00low000000
enalkirenpeptide00low000000
kynostatin 272peptide00low000000
terlakirenpeptide00low000000
kni 102peptide00low000000
pidotimodpeptide00low000000
cefpimizolepeptide00low000000
aspoxicillinpeptide00low000000
pro-diazepampeptide00low000000
moexiprilpeptide00low000000
mci 9038peptide00low000000
leucylleucinepeptide00low000000
diprotin apeptide00low000000
fk 888peptide00low000000
calpain inhibitor 2peptide00low000000
formylmethionyl-leucyl-phenylalanine methyl esterpeptide00low000000
t-kininpeptide00low000000
3-(n-maleimidopropionyl)biocytinpeptide00low000000
cefbuperazonecephalosporin;
peptide
00low000000
endothelin (16-21)peptide00low000000
n-valyltryptophanpeptide00low000000
neurotensin (1-8)peptide zwitterion;
peptide
human metabolite00low000000
alanylaspartic acidpeptide00low000000
fibrinpeptide00low000000
n-carbobenzoxyglycylprolinepeptide00low000000
s-(4-azidophenacyl)glutathionepeptide00low000000
bq 485peptide00low000000
phenylalanine arginine beta-naphthylamidepeptide00low000000
teprotidepeptide00low000000
ro 09-1437peptide00low000000
N-[2-[[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]-(thiophen-2-ylmethyl)amino]-2-oxoethyl]-2-furancarboxamidepeptide00low000000
N-[2-[1,3-benzodioxol-5-yl-[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-furancarboxamidepeptide00low000000
N-[1-[(1-amino-4-methyl-1-oxopentan-2-yl)amino]-3-methyl-1-oxopentan-2-yl]carbamic acid tert-butyl esterpeptide00low000000
N-tert-butyl-N-[2-(tert-butylamino)-2-oxoethyl]-3-(3,4-dihydro-2H-quinolin-1-yl)propanamidepeptide00low000000
N-[2-[1,3-benzodioxol-5-yl-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-furancarboxamidepeptide00low000000
N-[2-(4-chloro-N-[2-(cyclohexylamino)-2-oxoethyl]anilino)-2-oxoethyl]-2-furancarboxamidepeptide00low000000
2-[(2-acetamido-1-oxoethyl)amino]-3-phenylpropanoic acid ethyl esterpeptide00low000000
deltorphinpeptide00low000000
angiotensin iii, 5-ile-peptide00low000000
N-[2-[butyl-[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-thiophenecarboxamidepeptide00low000000
2-[[2-(cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-[1-oxo-2-[[oxo(thiophen-2-yl)methyl]amino]ethyl]amino]acetic acid ethyl esterpeptide00low000000
N-[2-[[2-(cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-(2-methoxyethyl)amino]-2-oxoethyl]-2-furancarboxamidepeptide00low000000
4-hydroxy-1-[1-oxo-2-(phenylmethoxycarbonylamino)propyl]-2-pyrrolidinecarboxylic acidpeptide00low000000
4-hydroxy-1-[1-oxo-2-[[1-oxo-2-(phenylmethoxycarbonylamino)ethyl]amino]propyl]-2-pyrrolidinecarboxylic acid (phenylmethyl) esterpeptide00low000000
2-[(2-acetamido-1-oxoethyl)amino]-N-(4-methoxyphenyl)-2-(4-methylphenyl)acetamidepeptide00low000000
mureidomycin apeptide00low000000
kallidinpeptide00low000000
delaprilpeptide00low000000
delaprilpeptide00low000000
(2R)-2-[[(2R,3R,4R)-2-amino-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-3-methyl-1-oxobutyl]amino]-2-[(2S,3R,4S,5S)-5-(2,4-dioxo-1-pyrimidinyl)-3,4-dihydroxy-2-oxolanyl]acetic acidpeptide00low000000
enkephalin, ala(2)-mephe(4)-gly(5)-peptide00low000000
l 685458carbamate ester;
monocarboxylic acid amide;
peptide;
secondary alcohol
EC 3.4.23.46 (memapsin 2) inhibitor;
peptidomimetic
00low000000
alvimopan anhydrouspeptide00low000000
s-(1,2-dichlorovinyl)glutathionepeptide00low000000
cyanoginosin-lapeptide00low000000
(3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acidpeptide00low000000
lenampicillinpeptide00low000000
glycyl-alanyl-leucinepeptide00low000000
leucyl-leucine-methyl esterpeptide00low000000
valyl-valyl-valinepeptide00low000000
(3S)-N-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxoethyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamidepeptide00low000000
ly 450139peptide00low000000
flag peptidepeptide00low000000
carbobenzoxy-leucyl-leucyl-norvalinalpeptide00low000000
l 692585peptide00low000000
deltorphin ii, ala(2)-peptide00low000000
deltorphin i, ala(2)-peptide00low000000
eledoisinpeptide00low000000
icg 001peptide00low000000
darinaparsinpeptide00low000000
ubenimexpeptide00low000000
rhizocticin apeptide00low000000
(2S)-2-[[[1-[(2S)-3-methyl-2-[(4-methylphenyl)sulfonylamino]-1-oxobutyl]-4-piperidinyl]-oxomethyl]amino]-2-phenylacetic acidpeptide00low000000
(2R)-2-[[(3S)-3-acetamido-3-carboxy-1-oxopropyl]amino]pentanedioic acidpeptide00low000000
alamandinepeptide00low000000
(3S)-3-[[[(2S)-1-[(2S)-2-[[(4-amino-3-chlorophenyl)-oxomethyl]amino]-3,3-dimethyl-1-oxobutyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-cyanopropanoic acidpeptide00low000000
tuftsinpeptide00low000000
microcystinpeptide00low000000
thiocoralinepeptide00low000000
glutamyl-valyl-glycinepeptide00low000000
prolyl-glycyl-prolinepeptide00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
potassium chlorideinorganic chloride;
inorganic potassium salt;
potassium salt
fertilizer2008200816.0medium000100
substance ppeptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
1994199430.0medium001000
arginylphenylalaninamide1995199529.0medium001000
locustakinin1995199529.0high001000
locustatachykinin ii protein, locusta migratoria1995199529.0high001000
lypressincyclic peptide1995199529.0medium001000
allatostatin 11995199529.0medium001000
perisulfakinin1995199529.0high001000
corazonin protein, insect1995199529.0medium001000
allatotropin1995199529.0medium001000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Muscle Contraction02006200618.0high000100